Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGASYS plus Ribavirin in Hemophilia A and Chronic Hepatitis C
NCT00475072Phase 4Completed
- Sponsor
- Roche
- Start
- Jun 2003
- Primary completion
- Jul 2006
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a in hepatitis C virus infection, sponsored by Roche. Started Jun 2003; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT00475072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00475072.